The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

The following is a summary of “Patients with PSOriasis and Suppurative Hidradenitis (PSO-SH) share genetic risk factors and are at risk of increased morbidity.,” published in the February 2025 issue ...

Discover studies that have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with ...